Department of Chemistry, Washington University in St. Louis, St. Louis, Missouri, 63130, USA.
Adv Mater. 2013 Oct 18;25(39):5609-14. doi: 10.1002/adma.201302842. Epub 2013 Sep 3.
A degradable polyphosphoester (PPE)-based cationic nanoparticle (cSCK), which is integrated constructed as a novel degradable drug device, demonstrates surprisingly efficient inhibition of inducible nitric oxide synthase (iNOS) transcription, and eventually inhibits nitric oxide (NO) over-production, without loading of any specific therapeutic drugs. This system may serve as a promising anti-inflammatory agent toward the treatment of acute lung injury.
一种可降解的聚磷酸酯(PPE)基阳离子纳米颗粒(cSCK),作为一种新型的可降解药物装置,被集成构建,它能够显著抑制诱导型一氧化氮合酶(iNOS)的转录,最终抑制一氧化氮(NO)的过度产生,而无需装载任何特定的治疗药物。该系统有望成为一种治疗急性肺损伤的抗炎药物。